Mutant TP53 posttranslational modifications: challenges and opportunities.
about
p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum Concept53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration.Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifsFunctional Diversification after Gene Duplication: Paralog Specific Regions of Structural Disorder and Phosphorylation in p53, p63, and p73TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients.Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDRTP53 mutants in the tower of babel of cancer progression.TP53 mutations in human cancer: database reassessment and prospects for the next decade.The TP53 gene network in a postgenomic era.Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters.Targeting mutant p53 in cancer: a long road to precision therapy.Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 ComplexMutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion.In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesNatural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer.A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.The p53 Pathway in Glioblastoma
P2860
Q28079390-CA1703A7-748A-4C6E-93FA-9D999B8F1A91Q30786652-A09AD4F1-25D6-4C01-B808-94EBFE9A799CQ34158315-D4A7DDD1-4EF2-4C06-8696-E65F68DE4E1DQ35966468-D21EE9C6-69A6-488B-A4D2-9519CF374FB4Q36889861-0EB470DC-B8F6-4788-846D-BEC35AE4FDFFQ37687017-D9C2E750-BBD9-40A0-A99C-3EFD30C2E53AQ38180665-879D35B0-D6D2-4C15-BC63-31D05DAE2E0AQ38199075-F3B89809-A74B-4129-BFB9-D72BD805DF52Q38206172-B058B794-F831-4075-AE82-B434EBF9EA05Q38984847-8E431F68-A006-4B19-AF1D-172CD36DC062Q38997351-BD02E906-1D56-4576-8AD0-541E5535EA12Q39029101-36547047-CF5D-453C-87E7-81C49072E738Q39229004-9409E9C1-D5FB-4DE8-A281-0069E466E669Q41225724-6EDDEEAF-19D3-44E8-93EE-149A88063431Q41395890-389EA130-3F8F-4698-AAA8-65EA5B5F0E89Q47673940-5BEFCDCF-1A30-4BBE-9EA5-E7DFD90E51EDQ50963273-357F848A-86C9-4884-BA42-742512685B4BQ57162865-428DA569-92CF-4C31-9EDF-47A65853434A
P2860
Mutant TP53 posttranslational modifications: challenges and opportunities.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mutant TP53 posttranslational modifications: challenges and opportunities.
@ast
Mutant TP53 posttranslational modifications: challenges and opportunities.
@en
type
label
Mutant TP53 posttranslational modifications: challenges and opportunities.
@ast
Mutant TP53 posttranslational modifications: challenges and opportunities.
@en
prefLabel
Mutant TP53 posttranslational modifications: challenges and opportunities.
@ast
Mutant TP53 posttranslational modifications: challenges and opportunities.
@en
P2860
P356
P1433
P1476
Mutant TP53 posttranslational modifications: challenges and opportunities
@en
P2093
Carl W Anderson
Daniel Menendez
P2860
P304
P356
10.1002/HUMU.22506
P577
2014-02-11T00:00:00Z